Cancidas and hepatic failure 
Cancidas and hepatic failure Patient Reports February 10, 2012
Cancidas Side Effects Report #4757576-4
Cancidas side effect was reported by a Physician from UNITED STATES on Aug 23, 2005. Female patient, 45 years of age, was diagnosed with wound infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: candidiasis, hepatic artery thrombosis, hepatic failure, post procedural bile leak, retroperitoneal haematoma. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5055516-4
Cancidas side effect was reported by a Physician from CHINA on Mar 29, 2006. Male patient, 51 years of age, was diagnosed with sepsis
, lung infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, face oedema, flushing, hepatic failure, oedema peripheral, oliguria, rash . Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, CILASTATIN AND IMIPENEM, CILASTATIN AND IMIPENEM. Patient died on 04/01/2006.Cancidas Side Effects Report #4988686-4
Cancidas side effect was reported by a Physician from CHINA on Mar 29, 2006. Male patient, 51 years of age, was diagnosed with sepsis
, lung infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, flushing, hepatic failure, oedema, oliguria, rash , respiratory distress, respiratory failure. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, CILASTATIN AND IMIPENEM, CILASTATIN AND IMIPENEM. Patient died on 04/01/2006.Cancidas Side Effects Report #6075706-1
Cancidas side effect was reported by a Physician from GERMANY on Feb 10, 2009. Male patient, 14 years of age, was diagnosed with fungal sepsis, prophylaxis against graft versus host disease and was treated with Cancidas. After drug was administered, patient experienced the following side effects: graft versus host disease, hepatic failure. Cancidas dosage: unknown. Patient recovered.
Cancidas Side Effects Report #4823750-1
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Oct 28, 2005. Female patient, 52 years of age, was diagnosed with fungal infection
, renal transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acinetobacter infection, acute myocardial infarction, complications of transplanted kidney, cytolytic hepatitis, device related infection, fungal infection , hepatic failure, ischaemic cardiomyopathy, pneumonia . Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with TACROLIMUS. Patient died.Cancidas Side Effects Report #4832165-1
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Nov 02, 2005. Female patient, 52 years of age, was diagnosed with fungal infection
, renal transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with TACROLIMUS, CEFEPIME, COLISTIN, METHYLPREDNISOLONE. Patient died.Cancidas Side Effects Report #4844706-9
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Nov 16, 2005. Female patient, 52 years of age, was diagnosed with fungal infection
, renal transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, haemodialysis, hepatic failure, renal cyst, septic shock. Cancidas dosage: 70 MG/DAILY IV ; 50 MG/DAILY IV ; 35 MG/DAILY IV. During the same period patient was treated with TACROLIMUS, CEFEPIME, COLISTIN, METHYLPREDNISOLONE. Patient died.Cancidas Side Effects Report #5447687-2
Cancidas side effect was reported by a Physician from UNITED ARAB EMIRATES on Aug 29, 2007. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with evidence based treatment, pneumonia
, sepsis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, hepatic failure, oesophageal varices haemorrhage, pneumonia , renal failure acute. Cancidas dosage: unknown. During the same period patient was treated with MEROPENEM, LINEZOLID, TOBRAMYCIN. Patient was hospitalized and became disabled. Patient died.Cancidas Side Effects Report #5096231-0
Cancidas side effect was reported by a Pharmacist from UNITED STATES on Aug 29, 2006. Female patient, 85 years of age, was diagnosed with candidiasis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure. Cancidas dosage: unknown. During the same period patient was treated with AMIODARONA, FLUCONAZOLE, LEVOTHYROXINE, ACETAMINOPHEN, DILANTIN. Patient recovered.
Cancidas Side Effects Report #5101457-3
Cancidas side effect was reported by a Pharmacist from UNITED STATES on Aug 29, 2006. Female patient, 85 years of age, was diagnosed with candidiasis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cardiac failure, hepatic failure, sepsis
. Cancidas dosage: unknown. During the same period patient was treated with AMIODARONA, FLUCONAZOLE, LEVOTHYROXINE, ACETAMINOPHEN, DILANTIN. Patient died on 08/29/2006.Cancidas Side Effects Report #5515267-6
Cancidas side effect was reported by a Physician from GERMANY on Nov 07, 2007. Male patient, 71 years of age, weighting 187.4 lb, was diagnosed with candidiasis, atrial fibrillation
, pneumonia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic failure. Cancidas dosage: unknown. During the same period patient was treated with CORDAREX, PRIMAXIN, FORTUM, AVELOX. Patient was hospitalized. Patient recovered.Cancidas Side Effects Report #5048571-9
Cancidas side effect was reported by a Consumer or non-health professional from PORTUGAL on June 22, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic failure, hepatic necrosis, hypotension, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN. Patient died.
Cancidas Side Effects Report #5090883-7
Cancidas side effect was reported by a Health Professional from PORTUGAL on Aug 07, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, hepatic necrosis, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with CYTARABINE, PIPERACILLIN AND TAZOBACTAM, AMIKACIN, ACETAMINOPHEN. Patient recovered.
Cancidas Side Effects Report #5023777-3
Cancidas side effect was reported by a Physician from PORTUGAL on May 18, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with AMIKACIN, CYTARABINE, PIPERACILLIN. Patient died.
Cancidas Side Effects Report #5031653-5
Cancidas side effect was reported by a Physician from PORTUGAL on June 06, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, hepatic necrosis, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with AMIKACIN, CYTARABINE, PIPERACILLIN. Patient died.
Cancidas Side Effects Report #4922936-5
Cancidas side effect was reported by a Health Professional from FRANCE on Feb 15, 2006. Male patient, child 4 years of age, weighting 44.09 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, hepatitis
, off label use, pancreatitis. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE. Patient was hospitalized. Patient recovered.Cancidas Side Effects Report #5310544-6
Cancidas side effect was reported by a Physician from BELGIUM on Apr 17, 2007. Female patient, 31 years of age, was diagnosed with aspergillosis, tuberculosis
, histiocytosis haematophagic, mycoplasma infection, cytomegalovirus infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral aspergillosis, hepatic cirrhosis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, ETHAMBUTOL HYDROCHLORIDE, GLOBULIN, CLARITHROMYCIN, GANCICLOVIR, ISONIAZID AND PYRAZINAMIDE AND RIFAMPIN. Patient died on 11/26/2005.Cancidas Side Effects Report #5314832-9
Cancidas side effect was reported by a Physician from BELGIUM on Apr 17, 2007. Female patient, 31 years of age, was diagnosed with aspergillosis, tuberculosis
, histiocytosis haematophagic, mycoplasma infection, cytomegalovirus infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral aspergillosis, hepatic cirrhosis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, ETHAMBUTOL HYDROCHLORIDE, GLOBULIN, CLARITHROMYCIN, GANCICLOVIR, ISONIAZID AND PYRAZINAMIDE AND RIFAMPIN. Patient died on 11/26/2005.Cancidas Side Effects Report #5330099-X
Cancidas side effect was reported by a Physician from BELGIUM on May 11, 2007. Female patient, 31 years of age, was diagnosed with aspergillosis, tuberculosis
, histiocytosis haematophagic, mycoplasma infection, cytomegalovirus infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral aspergillosis, hepatic cirrhosis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, ETHAMBUTOL HYDROCHLORIDE, GLOBULIN, CLARITHROMYCIN, GANCICLOVIR, ISONIAZID AND PYRAZINAMIDE AND RIFAMPIN. Patient died on 11/26/2005.Cancidas Side Effects Report #4732231-5
Cancidas side effect was reported by a Health Professional from FRANCE on July 25, 2005. Female patient, 81 years of age, weighting 169.8 lb, was diagnosed with endocarditis
and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, lactic acidosis. Cancidas dosage: unknown. During the same period patient was treated with DALFOPRISTIN AND QUINUPRISTIN, TEICOPLANIN, PANTOPRAZOLE. Patient was hospitalized. Patient died on 06/27/2005.Cancidas Side Effects Report #4734695-X
Cancidas side effect was reported by a Health Professional from FRANCE on July 25, 2005. Female patient, 81 years of age, weighting 169.8 lb, was diagnosed with endocarditis
and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, lactic acidosis, renal failure. Cancidas dosage: unknown. During the same period patient was treated with DALFOPRISTIN AND QUINUPRISTIN, TEICOPLANIN, PANTOPRAZOLE. Patient was hospitalized. Patient died on 06/27/2005.Cancidas Side Effects Report #5156739-6
Cancidas side effect was reported by a Physician from UNITED STATES on Nov 15, 2006. Female patient, 50 years of age, was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure. Cancidas dosage: unknown. Patient recovered.